Fig. 4
From: NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis
Prognostic impact of NEDD4 in BC. a, b The Kaplan–Meier analysis indicates that higher NEDD4 expression is correlated with poor OS (log-rank test, P = 0.0024) and DFS (log-rank test, P = 0.0011). c–e The OS rate of patients with BC in different TNM stages. f High NEDD4 expression is correlated with a high risk of relapse in invaded lymph node tumors (log-rank test, P = 0.0276). g The OS rate of patients with BC who received adjuvant therapies. NEDD4, neural precursor cell-expressed developmentally downregulated gene 4; BCLNM, breast cancer with lymph node metastasis; DFS, disease-free survival; OS, overall survival; TNM, tumor–node–metastasis; BC, breast cancer